Cipher Pharmaceuticals Inc is making waves on the TSX with a notable gain.
Cipher Pharmaceuticals Inc (CPH.TO) is experiencing a positive surge in its stock price, rising by 4.55% in today's trading session, bringing its share price to CA$17.69. This upward movement highlights investor confidence in the company's recent performance.
Advertisement
Cipher Pharmaceuticals Inc
CPH.TO
CPH.TO
Cipher Pharmaceuticals Inc
WealthAwesomeMarket cap
$359.88M
P/E
9.1x
52W high
$20.56
52W low
$12.48
1W change
-1.12%
Beta
0.46
Analyst Price Targets
Based on analyst covering CPH
Wall Street analysts forecast CPH stock price to rise 40.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$19.95
+40.9% Upside
Current Price
C$14.16
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CPH's historical volatility
30-Day Vol
73.5%
Annualized
90-Day Vol
50.1%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$11.84
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$13.34 | C$10.35 โ C$17.19 |
| 60 trading days | C$12.57 | C$8.78 โ C$17.99 |
| 90 trading days | C$11.84 | C$7.63 โ C$18.38 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: With a strong profit margin of 60.6% and a P/E ratio of 10.13, Cipher Pharmaceuticals is showing robust financial health, making it an attractive option for investors looking for growth in the pharmaceutical sector.
4.55% Gain in One Day
Cipher Pharmaceuticals' stock has risen significantly today, reflecting strong investor sentiment and confidence in its market position.
Bull case
The recent increase in stock price shows that investors are optimistic about Cipher Pharmaceuticals' financial performance, especially after its impressive revenue growth in previous quarters. This could signal ongoing strength in operations and potential for future profits.
Bear case
Despite the positive movement, it's wise for investors to stay cautious. The lack of recent news or announcements might lead to volatility, and potential market corrections could affect the stock's performance soon.
Advertisement
Strong Financial Performance
Cipher Pharmaceuticals has consistently reported impressive financial results, including a net income of CA$6.2 million for Q1 2026, a remarkable 135% increase from the previous year. This strong performance is likely contributing to the stock's rise today.
Market Sentiment and Future Outlook
The positive movement in Cipher Pharmaceuticals' stock price today may also be due to favorable market sentiment surrounding the pharmaceutical sector. Investors are increasingly optimistic about the company's ability to sustain growth and profitability in the coming quarters.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
